PROK - ProKidney - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.633B

Cash

446.1M

Avg Qtr Burn

-19.88M

Short % of Float

31.75%

Insider Ownership

22.34%

Institutional Own.

65.36%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
REACT Details Chronic kidney disease	Phase 2/3 Data readout	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.